Oxair Gas Systems Ltd, a global manufacturer of on-site gas separation systems and air processing technology, has recently revealed its strategic vision for 2025.
The company plans to build on its development of innovative next-generation solutions to further challenge the concept of oxygen and nitrogen delivery across a diverse array of industries, including; oil and gas, gold mining, medical, food, water treatment, chemical and biotech.
Oxair’s chief engineer, David Cheeseman commented: “We are not merely anticipating change; we are actively driving innovation in the gas processing industry. Our commitment to technological advancement is now reshaping how critical industries access and utilise essential gases.”
The company’s existing commitment to challenging industry practices can be demonstrated through Oxair’s current portfolio of gas separation systems, which are already bringing a wealth of benefits to a variety of workplace environments.
One such example can be found within the healthcare sector, where Oxair’s revolutionary oxygen generator, the Medical Oxygen PSA, has proved instrumental in the delivery of high quality oxygen to patients. Unlike most systems, the Oxygen PSA delivers a constant oxygen purity of between 94% to 95% – which is above the recommended standard of 93% (+/- 3%). With global medical facilities increasingly focused on the need for a reliable post-pandemic oxygen supply chain, Oxair’s pioneering equipment has proved a cost-effective and convenient procurement option for many hospitals and healthcare providers.
With the company’s strategic focus now securely on research and development, Oxair looks set to be in a strong position to address any new emerging sector challenges as they arise.
It will be interesting to see just what the future brings for this innovative business but one thing is for sure, Oxair’s global position within the gas separation community looks set to remain firmly in place.
